GSK Pharma India Gets CDSCO Panel Nod for phase 3 CT of Belrestotug and Dostarlimab Dr. Divya Colin26 July 2024 6:00 PM ISTNew Delhi: The drug major GSK Pharma India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
GSK Pharma declares financial results for quarter ended March 31, 2024 Ruchika Sharma19 May 2024 10:00 AM ISTMumbai: GlaxoSmithKline (GSK) Pharmaceuticals Limited has declared financial results for the quarter ended March 31, 2024. Revenue for the quarter...
GSK Gets CDSCO Panel Nod to Study antimalarial drug Tafenoquine Dr. Divya Colin24 April 2024 6:00 PM ISTNew Delhi: The pharmaceutical major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Submit Separate Toxicity Data on Indian Subject: CDSCO Panel Tells GSK on BelantamabMafodotin study Dr. Divya Colin4 Jan 2024 6:00 PM ISTNew Delhi: Considering the serious adverse events in the study data (phase-I & II) of Belantamab Mafodotin (GSK2857916) for Injection 100mg...
GSK Gets CDSCO Panel Nod to study safety of anti-cancer drug Dostarlimab Dr. Divya Colin23 Dec 2023 6:00 PM ISTNew Delhi: Citing that the total number of evaluable patients in the study should be a minimum of 30, the Subject Expert Committee (SEC) functional...
Indian pharmaceutical market registers 9 percent growth in September: IQVIA Report Susmita Roy3 Nov 2023 5:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a spike of nine percent in September 2023, according to International Quality and...
GSK gets CDSCO panel Nod for Phase III Extension safety follow-up study for trial of RSVPreF3 vaccine Dr. Divya Colin12 July 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
GSK Pharma reports net profit at Rs 133 crore in Q4 Ruchika Sharma18 May 2023 2:30 PM ISTFor FY23, consolidated net profit from continuing operations was Rs 607.64 crore against Rs 380.77 crore in FY22.
GSK gets CDSCO Panel nod to import, market anticancer drug Dostarlimab Susmita Roy14 March 2023 6:00 PM ISTNew Delhi: Highlighting the unmet medical need in the country, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
GlaxoSmithKline to seek approval for 20 new medicines by 2020 Pooja Bhatia Bhatia4 Nov 2015 1:16 PM ISTBritish drugmaker GlaxoSmithKline has recently reported it strategy to boost its sales in the market, which in turn has been affected by the declining...
World's first malaria vaccine delayed as WHO experts urge caution Meghna A Singhania26 Oct 2015 1:12 PM ISTThe world's first malaria vaccine is promising but should be used on a pilot basis before any wide-scale use, given its limited efficacy, World Health...
GSK Pharma inhaled medicine fails the clinical trial Pooja Bhatia Bhatia10 Sept 2015 10:00 AM ISTThe inhaled medicine Breo by GSK Pharma failed to prolong life in patients with chronic respiratory disease, smashing all hopes for the sales boost...
